Legal & General Group PLC Rvl Pharmaceuticals PLC Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$2.8 - $3.78 $4,426 - $5,976	-1,581 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$4.82 - $8.77 $588 - $1,069	-122 Reduced 7.16%	1,581 $9,000
Q2 2020 Aug 14, 2020	BUY	$2.83 - $6.99 $894 - $2,208	316 Added 22.78%	1,703 $11,000
Q1 2020 May 14, 2020	SELL	$3.18 - $7.0 $422 - $931	-133 Reduced 8.75%	1,387 $5,000
Q4 2018 Feb 15, 2019	BUY	$6.25 - $9.2 $9,500 - $13,983	1,520 New	1,520 $12,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.